Enzyme

company

About

Enzyme provides no-code access to Web3 and allows creators and businesses to develop and implement smart contracts.

Details

Last Funding Type
Pre-seed
Last Funding Money Raised
$120K
Industries
Blockchain,Developer Tools
Founded date
Jan 1, 2020
Number Of Employee
1 - 10
Operating Status
Active
Legal Name
NoCode, Inc.

Enzyme provides no-code access to Web3 and allows creators and businesses to develop and implement smart contracts. Soon they will let people design smart contract interactions across multiple blockchains.

Enzyme is headquartered in New York, United States and was founded in 2020.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$120K
Enzyme has raised a total of $120K in funding over 2 rounds. Their latest funding was raised on Jan 25, 2021 from a Pre-seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 25, 2021 Pre-seed $120K 1 Techstars Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Enzyme is funded by 1 investors. Techstars are the most recent investors.
Investor Name Lead Investor Funding Round
Techstars Yes Pre-seed

Employee Profiles

Number of Employee Profiles
1
Enzyme has 1 current employee profiles, including Executive Teddy Pejoski
Executive